Summit Therapeutics
SMMT
#1912
Rank
A$15.38 B
Marketcap
A$20.66
Share price
-1.17%
Change (1 day)
-37.36%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: A$15.38 Billion

As of February 2026 Summit Therapeutics has a market cap of A$15.38 Billion. This makes Summit Therapeutics the world's 1912th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026A$15.38 B-23.7%
2025A$20.16 B-6.62%
2024A$21.58 B704.13%
2023A$2.68 B113.54%
2022A$1.25 B246.79%
2021A$0.36 B-27.89%
2020A$0.50 B227.52%
2019A$0.15 B471.59%
2018A$26.85 M-87.32%
2017A$0.21 B45.06%
2016A$0.14 B-24.54%
2015A$0.19 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Summit Therapeutics was reported to be:

A$15.38 Billion
by Nasdaq info icon info icon
A$15.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
A$2.96 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
A$0.32 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
A$0.38 B-97.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
A$8.83 B-42.57%๐Ÿ‡บ๐Ÿ‡ธ USA